Lundbeck, a pharmaceutical company dedicated to brain diseases, leverages neuroscience expertise to pioneer therapies for conditions like Alzheimer’s, Parkinson’s, and Depression. With a global presence spanning 100+ countries and a team of 5,500, we’re committed to supporting patients worldwide. Beyond developing widely prescribed treatments, we tackle mental illness stigma and prioritize sustainability. Our efforts extend to research, clinical trials, and partnerships aimed at innovating new treatment options. Lundbeck’s mission remains unwavering: to improve lives through breakthroughs in neuroscience, fostering hope and healing for those affected by brain disorders.